OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-BCL10 antibodies

Anti-BCL10 CONJUGATED Antibody Clone OTI6A4

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA400005 Anti-BCL10 mouse mAb, clone OTI6A4, PE conjugated 100 ul $325 In Stock
Add to Shopping Cart
spacer
FC(1)

OriGene Data

ImmunogenFull length human recombinant protein of human BCL10 (NP_003912) produced in HEK293T cell.
Clone NameClone OTI6A4 IsotypeIgG1
Species ReactivityHuman Concentration0.5 mg/ml
Guaranteed Application *FC Suggested DilutionsFC:1:50
Predicted MW Explanation 26.1 kDa
BufferPBS (pH7.4) containing 0.02% NaN3; store at 4C, do not freeze
Purification Purified from mouse ascites fluids by affinity chromatography

Reference Data

Target NameHomo sapiens B-cell CLL/lymphoma 10 (BCL10)
Alternative Namec-E10; CARMEN; CIPER; CLAP; IMD37; mE10
Database LinkNP_003912
FunctionThis gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. [provided by RefSeq].
Related PathwayDruggable Genome T cell receptor signaling pathwayB cell receptor signaling pathway

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

Jurkat T cells are fixed 2% formaldehyde for 20 min, then permeabilized with 0.1% saponin. The cells are then stained with a PE-labeled isotope control antibody, or 4A8 or 6A4 anti-Bcl10 antibodies.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title

Notice to Non-US Customers

ExclaimationWeb price and delivery time are for direct sales only.

Non-US customers are encouraged to contact our dedicated distributor network for quotes and streamlined ordering/delivery support.

Acknowledge